Table 3.
Prevalence of cancer treatment types.
| EU total n = 444 | N/n | Chemotherapy (26%) | Surgery (17%) | Hormonal (17%) | Targeted (14%) | Radiation (13%) | Adjunctive chemotherapy (10%) | Targeted immunotherapy (5%) | Immunotherapy/biological (5%) | Palliative care (2%) | Others (47%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UK | 87 | 20% | 16% | 5% | 3% | 15% | 10% | 7% | 3% | 2% | 54% | |
| Spain | 44 | 25% | 9% | 5% | 0% | 9% | 5% | 0% | 5% | 2% | 66% | |
| France | 72 | 32% | 28% | 25% | 15% | 18% | 14% | 1% | 6% | 3% | 54% | |
| Italy | 64 | 27% | 19% | 30% | 27% | 3% | 19% | 2% | 6% | 0% | 20% | |
| Germany | 107 | 29% | 14% | 19% | 25% | 12% | 3% | 9% | 2% | 0% | 42% | |
| Netherlands | 35 | 29% | 20% | 20% | 3% | 17% | 3% | 3% | 11% | 14% | 51% | |
| The Nordics | 20 | 20% | 20% | 15% | 5% | 5% | 25% | 0% | 15% | 0% | 50% | |
| Switzerland | 2 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 50% | 50% | |
| Austria | 11 | 27% | 9% | 27% | 9% | 64% | 18% | 45% | 9% | 0% | 36% | |
| Belgium | 2 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 100% | |
| Portugal | 0 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| High to low prevalence | ||||||||||||
Total % may be >100% due to mention of multiple themes in posts.
NA, not applicable.